More Clinical Articles

Access and Evidence

Window dressing: Roche Launches New Process for Accessing Clinical Trial Data

Zuzanna Fimińska, (Feb 27, 2013)

Roche announced they will set up an 'independent body of recognized experts' to evaluate and approve requests to access patient-level clinical trial data by third party researchers.
Clinical

Obama Administration Calls for Research Transparency

Louise Kelly, (Feb 26, 2013)

An online petition demanding free access over the Internet to scientific journal articles arising from taxpayer-funded research has forced the White House to take action. Is this a ground-breaking development or simply a clever sidestep?
Access and Evidence

NICE Backs All Trials Campaign

Zuzanna Fimińska, (Feb 26, 2013)

The UK National Institute for Health and Clinical Excellence (NICE) joined the supporters of the All Trials campaign, which calls on responsible bodies to ensure that all trials, past and present, for all treatments, are registered and that the full methods and full results are published.
Access and Evidence

An Increase in Drug Approvals – But at What Cost?

Ben Steele, (Feb 22, 2013)

The BMJ Open journal has reports that the number of new drugs introduced into the UK over the last thirty years has been rising, not falling. The bigger picture however, shows the rising costs of drug development and the steady decline of the R&D talent pool are still proving problematic.
Clinical

National Clinical Trials Network will Facilitate Research Recruitment in the US

Zuzanna Fimińska, (Feb 19, 2013)

A service linking medical researchers with physicians' practices, specialized care centers and other healthcare providers will be launched in the fourth quarter of 2013.
Access and Evidence

Merck Settles Vytorin Clinical Trials Data Lawsuit For US$688 Million

Lucy Brake, (Feb 19, 2013)

In what is claimed to be one of the top 25 securities class action settlements of all time, Merck & CO has settled investor claims that the company withheld negative data from clinical trials on Vytorin.
Clinical

Battling Bacteria: The Drive to Develop New Drugs

Louise Kelly, (Feb 12, 2013)

With few new drugs currently making it to market, the growing threat of resistance to antibiotics has become a very real concern. Big Pharma are now backing a European based program to research this issue, its first two projects receiving combined funding of more than €200m.
Clinical

Alzheimer’s Disease Research – A Different Approach

Matthew Wood, (Feb 8, 2013)

A paradigm shift in developing treatments for patients with Alzheimer’s disease is about to be set into motion following the publication of draft guidelines issued by the FDA.
Access and Evidence

Mandatory Compensation for Clinical Trial Injuries in India

Louise Kelly, (Feb 7, 2013)

A lack of reasonable care and financial compensation has long been associated with clinical trials conducted in India, but this situation is set to change dramatically as the Indian government introduce stricter compensation laws & regulations for clinical trials.
Clinical

Pharma Faces Talent Gap as R&D Strategy Changes

Ben Steele, (Feb 6, 2013)

After a decade of layoffs, pharma is having to face up to the fact that their cost-cutting strategy has left them with a talent gap that may harm their efforts at increasing R&D productivity.

Pages